The observed increase in macrophage phagocytosis and tumor-infiltrating CD4+ and CD8+ cells in breast cancer cells suggests that altering macrophage clock gene expression via MCS could enhance the antitumor activity of immune cells against breast cancer. Here, CD8A is linked to breast carcinoma.